Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Walcher, Daniel ^a   Walcher, Thomas ^a   Bernhardt, Peter ^a   Vasic, Dusica ^a   Bach, Helga ^a   Durst, Renate ^a   Rottbauer, Wolfgang ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

F ACTIN; INTERCELLULAR ADHESION MOLECULE 3; IVABRADINE; MYOSIN LIGHT CHAIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAC PROTEIN; RANTES; STROMAL CELL DERIVED FACTOR 1; ACTIN; BENZAZEPINE DERIVATIVE; CELL ADHESION MOLECULE; CHEMOKINE; CXCL12 PROTEIN, HUMAN; ENZYME INHIBITOR; ICAM3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; PROTEIN KINASE B; RAC1 PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE MIGRATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANIMAL; ATHEROSCLEROSIS; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; ENZYME ACTIVATION; IMMUNOLOGY; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS; UROPODA;

ACTINS; ANIMALS; ANTIGENS, CD; ATHEROSCLEROSIS; BENZAZEPINES; CD4-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL MOVEMENT; CHEMOKINE CCL5; CHEMOKINE CXCL12; CHEMOKINES; ENZYME ACTIVATION; ENZYME INHIBITORS; HUMANS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RAC1 GTP-BINDING PROTEIN;

EID: 79251534370     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/751313     Document Type: Article

References (28)

1. Hansson G. K., Mechanisms of disease: inflammation, atherosclerosis, and coronary artery disease New England Journal of Medicine 2005 352 16 1685 1626
2. Zernecke A., Weber C., Inflammatory mediators in atherosclerotic vascular disease Basic Research in Cardiology 2005 100 2 93 101
3. Heller E. A., Liu E., Tager A. M., Yuan Q., Lin A. Y., Ahluwalia N., Jones K., Koehn S. L., Lok V. M., Aikawa E., Moore K. J., Luster A. D., Gerszten R. E., Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells Circulation 2006 113 19 2301 2312
4. Veillard N. R., Steffens S., Pelli G., Lu B., Kwak B. R., Gerard C., Charo I. F., Mach F., Differential influence of chemokine receptors CCR2 and CXCR3 in development of atherosclerosis in vivo Circulation 2005 112 6 870 878
5. Kannel W. B., Kannel C., Paffenbarger R. S. Jr., Cupples A., Heart rate and cardiovascular mortality: the Framingham study American Heart Journal 1987 113 6 1489 1494
6. Hjalmarson A., Gilpin E. A., Kjekshus J., Schieman G., Nicod P., Henning H., Ross J., Influence of heart rate on mortality after acute myocardial infarction American Journal of Cardiology 1990 65 9 547 553
7. Diaz A., Bourassa M. G., Guertin M. C., Tardif J. C., Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease European Heart Journal 2005 26 10 967 974
8. Reil J. C., Bhm M., The role of heart rate in the development of cardiovascular disease Clinical Research in Cardiology 2007 96 9 585 592
9. Sajadieha A., Nielsen O. W., Rasmussen V., Hein H. O., Abedini S., Hansen J. F., Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease European Heart Journal 2004 25 5 363 370
10. Heidland U. E., Strauer B. E., Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption Circulation 2001 104 13 1477 1482
11. Custodis F., Baumhkel M., Schlimmer N., List F., Gensch C., Bhm M., Laufs U., Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice Circulation 2008 117 18 2377 2387
12. Walcher D., Aleksic M., Jerg V., Hombach V., Zieske A., Homma S., Strong J., Marx N., C-peptide induces chemotaxis of human CD4-positive cells: Involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase Diabetes 2004 53 7 1664 1670
13. Walcher D., Hess K., Heinz P., Petscher K., Vasic D., Kintscher U., Clemenz M., Hartge M., Raps K., Hombach V., Marx N., Telmisartan inhibits CD4-positive lymphocyte migration independent of the angiotensin type 1 receptor via peroxisome proliferator-activated receptor-γ Hypertension 2008 51 2 259 266
14. Ryu J. W., Hong K. H., Maeng J. H., Kim J. B., Ko J., Park J. Y., Lee KI. U., Hong M. K., Park S. W., Kim Y. H., Han K. H., Overexpression of uncoupling protein 2 in THP1 monocytes inhibits 2 integrin-mediated firm adhesion and transendothelial migration Arteriosclerosis, Thrombosis, and Vascular Biology 2004 24 5 864 870
15. Al-Aoukaty A., Rolstad B., Maghazachi A. A., Recruitment of pleckstrin and phosphoinositide 3-kinase into the cell membranes, and their association with G after activation of NK cells with chemokines Journal of Immunology 1999 162 6 3249 3255
16. Cantrell D., Protein kinase B (Akt) regulation and function in T lymphocytes Seminars in Immunology 2002 14 1 19 26
17. Fujita T., Azuma Y., Fukuyama R., Hattori Y., Yoshida C., Koida M., Ogita K., Komori T., Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling Journal of Cell Biology 2004 166 1 85 95
18. Ridley A. J., Rho GTPases and cell migration Journal of Cell Science 2001 114 15 2713 2722
19. Raftopoulou M., Hall A., Cell migration: Rho GTPases lead the way Developmental Biology 2004 265 1 23 32
20. Burridge K., Wennerberg K., Rho and Rac take center stage Cell 2004 116 2 167 179
21. Amano M., Ito M., Kimura K., Fukata Y., Chihara K., Nakano T., Matsuura Y., Kaibuchi K., Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase) Journal of Biological Chemistry 1996 271 34 20246 20249
22. Arber S., Barbayannis F. A., Hanser H., Schnelder C., Stanyon C. A., Bernards O., Caroni P., Regulation of actin dynamics through phosphorylation of cofilin by LIM-kinase Nature 1998 393 6687 805 809
23. Serrador J. M., Nieto M., Snchez-Madrid F., Cytoskeletal rearrangement during migration and activation of T lymphocytes Trends in Cell Biology 1999 9 6 228 292
24. Snchez-Madrid F., del Pozo M. A., Leukocyte polarization in cell migration and immune interactions EMBO Journal 1999 18 3 501 511
25. Tardif J. C., Ford I., Tendera M., Bourassa M. G., Fox K., Efficacy of ivabradine, a new selective I inhibitor, compared with atenolol in patients with chronic stable angina European Heart Journal 2005 26 23 2529 2536
26. Borer J. S., Fox K., Jaillon P., Lerebours G., Antianginal and antiischemic effects of ivabradine, an I inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial Circulation 2003 107 6 817 823
27. Braunersreuther V., Zernecke A., Arnaud C., Liehn E. A., Steffens S., Shagdarsuren E., Bidzhekov K., Burger F., Pelli G., Luckow B., Mach F., Weber C., Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice Arteriosclerosis, Thrombosis, and Vascular Biology 2007 27 2 373 379
28. Bernhagen J., Krohn R., Lue H., Gregory J. L., Zernecke A., Koenen R. R., Dewor M., Georgiev I., Schober A., Leng L., Kooistra T., Fingerle-Rowson G., Ghezzi P., Kleemann R., McColl S. R., Bucala R., Hickey M. J., Weber C., MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment Nature Medicine 2007 13 5 587 596